Dyne Therapeutics, Inc. Current Ratio

Current Ratio of DYN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Current Ratio growth rates and interactive chart. The current ratio is a liquidity ratio that measures whether a firm has enough resources to meet its short-term obligations. It is calculated as current assets divided by current liabilities. A ratio below 1 indicates potential trouble for a company, as it doesn't have enough current assets to pay for its short-term liabilities. A ratio above 2 is usually considered healthy.

Highlights and Quick Summary

  • Current Ratio for the quarter ending June 30, 2023 was 10.54 (a -8.68% decrease compared to previous quarter)
  • Year-over-year quarterly Current Ratio decreased by -4.79%
  • Annual Current Ratio for 2022 was 9.46 (a -28.97% decrease from previous year)
  • Annual Current Ratio for 2021 was 13.31 (a -58.18% decrease from previous year)
  • Annual Current Ratio for 2020 was 31.83 (a 408.55% increase from previous year)
Visit stockrow.com/DYN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Current Ratio of Dyne Therapeutics, Inc.

Most recent Current Ratioof DYN including historical data for past 10 years.

Interactive Chart of Current Ratio of Dyne Therapeutics, Inc.

Dyne Therapeutics, Inc. Current Ratio for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 10.54 11.54 – – –
2022 9.46 11.07 11.63 14.82 9.46
2021 13.31 18.19 31.7 36.21 13.31
2020 – – 31.83 81.2 31.83
2019 – – – 6.26 6.26
2018 – – – – 11.47

Business Profile of Dyne Therapeutics, Inc.

Sector: Healthcare
Industry: Biotechnology
© stockrow.com